Kraig Biocraft Labs Stock Current Valuation
| KBLB Stock | USD 0.09 0.0001 0.11% |
Valuation analysis of Kraig Biocraft Labs helps investors to measure Kraig Biocraft's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Kraig Biocraft's price fluctuation is out of control at this time. Calculation of the real value of Kraig Biocraft Labs is based on 3 months time horizon. Increasing Kraig Biocraft's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Kraig otc stock is determined by what a typical buyer is willing to pay for full or partial control of Kraig Biocraft Labs. Since Kraig Biocraft is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kraig OTC Stock. However, Kraig Biocraft's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.09 | Real 0.0756 | Hype 0.09 | Naive 0.0899 |
The real value of Kraig OTC Stock, also known as its intrinsic value, is the underlying worth of Kraig Biocraft Labs OTC Stock, which is reflected in its stock price. It is based on Kraig Biocraft's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Kraig Biocraft's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Kraig Biocraft Labs helps investors to forecast how Kraig otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kraig Biocraft more accurately as focusing exclusively on Kraig Biocraft's fundamentals will not take into account other important factors: Kraig Biocraft Labs OTC Stock Current Valuation Analysis
Kraig Biocraft's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Kraig Biocraft Current Valuation | 34.14 M |
Most of Kraig Biocraft's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kraig Biocraft Labs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Kraig Biocraft Labs has a Current Valuation of 34.14 M. This is 99.7% lower than that of the Chemicals sector and 99.89% lower than that of the Materials industry. The current valuation for all United States stocks is 99.79% higher than that of the company.
Kraig Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kraig Biocraft's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Kraig Biocraft could also be used in its relative valuation, which is a method of valuing Kraig Biocraft by comparing valuation metrics of similar companies.Kraig Biocraft is currently under evaluation in current valuation category among its peers.
Kraig Fundamentals
| Return On Asset | -0.32 | |||
| Current Valuation | 34.14 M | |||
| Shares Outstanding | 1.02 B | |||
| Shares Owned By Insiders | 25.29 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Earning | (9.37) X | |||
| Price To Sales | 1,199 X | |||
| EBITDA | (2.64 M) | |||
| Net Income | (8.05 M) | |||
| Cash And Equivalents | 4.82 M | |||
| Total Debt | 95.24 K | |||
| Current Ratio | 0.53 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (1.8 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 38 | |||
| Beta | 0.34 | |||
| Market Capitalization | 38.03 M | |||
| Total Asset | 3.02 M | |||
| Retained Earnings | (22.47 M) | |||
| Working Capital | (2.32 M) | |||
| Current Asset | 356 K | |||
| Current Liabilities | 2.68 M | |||
| Net Asset | 3.02 M |
About Kraig Biocraft Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kraig Biocraft Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kraig Biocraft using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kraig Biocraft Labs based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kraig OTC Stock
Kraig Biocraft financial ratios help investors to determine whether Kraig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kraig with respect to the benefits of owning Kraig Biocraft security.